Regulatory PathRegulatory requirements compared

Active substance

Penicillamine

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
PenicillAMINE250 mgCapsule, hard · Oral use100 BottleSAR 336.95Generic · PrescriptionNavinta LLCValid
ARTAMIN 150 MG CAPS150 mgCapsule · Oral use50 BlisterSAR 61.85NCE · PrescriptionSANDOZWithdrawn by MAH · Not Marketed
ARTAMIN 250 MG CAPS250 mgCapsule · Oral use50 BlisterSAR 74.45NCE · PrescriptionSANDOZWithdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
CUPRIMINE250MGcapsule · oralVALEANT PHARMS INTLPrescription4 Dec 1970
DEPEN250MGtablet · oralMYLAN SPECIALITY LPPrescription8 Nov 1978
PENICILLAMINE250MGcapsule · oralWATSON LABS INCPrescription24 Jun 2019
PENICILLAMINE250MGtablet · oralPH HEALTHPrescription23 Dec 2019
PENICILLAMINE250MGcapsule · oralPH HEALTHPrescription23 Dec 2019
PENICILLAMINE250MGcapsule · oralDR REDDYSPrescription4 Aug 2020
PENICILLAMINE250MGtablet · oralLUPINPrescription30 Nov 2020
PENICILLAMINE250MGcapsule · oralGRANULESPrescription2 Dec 2020
PENICILLAMINE250MGcapsule · oralINVAGEN PHARMSPrescription19 Aug 2021
PENICILLAMINE250MGcapsule · oralBRECKENRIDGEPrescription23 Aug 2021
PENICILLAMINE250MGcapsule · oralNAVINTA LLCPrescription8 Oct 2021
CUPRIMINE125MGcapsule · oralVALEANT PHARMS INTLDiscontinued4 Dec 1970
LUXZYLA250MGcapsule · oralANI PHARMSDiscontinued7 May 2019
PENICILLAMINE250MGtablet · oralTEVA PHARMS USADiscontinued13 Feb 2020
PENICILLAMINE250MGcapsule · oralAPOTEXDiscontinued28 Apr 2020

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
CUPRIMINE00016055250 MGCAPSULE · ORALBAUSCH HEALTH, CANADA INC.

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
NHS Drug TariffPenicillamine 125mg tablets£93.1156 tablet1 Oct 2026
NHS Drug TariffPenicillamine 250mg tablets£140.0056 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

WHO WHO Model List of Essential Medicines (2025)

  • 4.2. Antidotes and other substances used in poisonings > Specific · core
    Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified
    Oral > Solid: 250 mg
  • 29.2. Disease-modifying anti-rheumatic drugs (DMARDs) · complementary
    Rheumatoid arthritis, serology unspecified
    Oral > Solid: 250 mg

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.